Logo image of PHI

PLDT INC-SPON ADR (PHI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PHI - US69344D4088 - ADR

21.74 USD
0 (0%)
Last: 12/31/2025, 8:23:42 PM
21.74 USD
0 (0%)
After Hours: 12/31/2025, 8:23:42 PM
Fundamental Rating

4

Overall PHI gets a fundamental rating of 4 out of 10. We evaluated PHI against 22 industry peers in the Wireless Telecommunication Services industry. While PHI belongs to the best of the industry regarding profitability, there are concerns on its financial health. PHI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

PHI had positive earnings in the past year.
PHI had a positive operating cash flow in the past year.
PHI had positive earnings in each of the past 5 years.
Each year in the past 5 years PHI had a positive operating cash flow.
PHI Yearly Net Income VS EBIT VS OCF VS FCFPHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

With a decent Return On Assets value of 4.65%, PHI is doing good in the industry, outperforming 63.64% of the companies in the same industry.
The Return On Equity of PHI (24.31%) is better than 81.82% of its industry peers.
PHI has a better Return On Invested Capital (8.37%) than 72.73% of its industry peers.
PHI had an Average Return On Invested Capital over the past 3 years of 5.82%. This is in line with the industry average of 6.45%.
The last Return On Invested Capital (8.37%) for PHI is above the 3 year average (5.82%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.65%
ROE 24.31%
ROIC 8.37%
ROA(3y)3.73%
ROA(5y)3.92%
ROE(3y)20.92%
ROE(5y)21.02%
ROIC(3y)5.82%
ROIC(5y)6.78%
PHI Yearly ROA, ROE, ROICPHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

PHI has a Profit Margin of 13.35%. This is in the better half of the industry: PHI outperforms 77.27% of its industry peers.
PHI's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 23.74%, PHI belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Operating Margin of PHI has remained more or less at the same level.
PHI's Gross Margin of 86.54% is amongst the best of the industry. PHI outperforms 90.91% of its industry peers.
In the last couple of years the Gross Margin of PHI has remained more or less at the same level.
Industry RankSector Rank
OM 23.74%
PM (TTM) 13.35%
GM 86.54%
OM growth 3Y1.9%
OM growth 5Y0.33%
PM growth 3Y2.8%
PM growth 5Y2.3%
GM growth 3Y-1.41%
GM growth 5Y-0.63%
PHI Yearly Profit, Operating, Gross MarginsPHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHI is creating value.
Compared to 1 year ago, PHI has about the same amount of shares outstanding.
Compared to 5 years ago, PHI has about the same amount of shares outstanding.
The debt/assets ratio for PHI is higher compared to a year ago.
PHI Yearly Shares OutstandingPHI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
PHI Yearly Total Debt VS Total AssetsPHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.2 Solvency

PHI has an Altman-Z score of 0.84. This is a bad value and indicates that PHI is not financially healthy and even has some risk of bankruptcy.
PHI's Altman-Z score of 0.84 is in line compared to the rest of the industry. PHI outperforms 40.91% of its industry peers.
PHI has a debt to FCF ratio of 20.27. This is a negative value and a sign of low solvency as PHI would need 20.27 years to pay back of all of its debts.
PHI has a Debt to FCF ratio of 20.27. This is in the lower half of the industry: PHI underperforms 63.64% of its industry peers.
A Debt/Equity ratio of 2.76 is on the high side and indicates that PHI has dependencies on debt financing.
The Debt to Equity ratio of PHI (2.76) is worse than 77.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.76
Debt/FCF 20.27
Altman-Z 0.84
ROIC/WACC3.08
WACC2.72%
PHI Yearly LT Debt VS Equity VS FCFPHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B 300B

2.3 Liquidity

A Current Ratio of 0.38 indicates that PHI may have some problems paying its short term obligations.
PHI has a Current ratio of 0.38. This is amonst the worse of the industry: PHI underperforms 90.91% of its industry peers.
A Quick Ratio of 0.37 indicates that PHI may have some problems paying its short term obligations.
PHI's Quick ratio of 0.37 is on the low side compared to the rest of the industry. PHI is outperformed by 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.37
PHI Yearly Current Assets VS Current LiabilitesPHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

3

3. Growth

3.1 Past

The earnings per share for PHI have decreased by -2.37% in the last year.
PHI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.18% yearly.
PHI shows a small growth in Revenue. In the last year, the Revenue has grown by 1.69%.
PHI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.09% yearly.
EPS 1Y (TTM)-2.37%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%-10.71%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%0.66%

3.2 Future

PHI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.22% yearly.
The Revenue is expected to grow by 2.17% on average over the next years.
EPS Next Y-0.88%
EPS Next 2Y1.39%
EPS Next 3Y2.22%
EPS Next 5YN/A
Revenue Next Year1.37%
Revenue Next 2Y2%
Revenue Next 3Y2.17%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PHI Yearly Revenue VS EstimatesPHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50B 100B 150B 200B
PHI Yearly EPS VS EstimatesPHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50 100 150

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.17, the valuation of PHI can be described as very reasonable.
Based on the Price/Earnings ratio, PHI is valued cheaper than 100.00% of the companies in the same industry.
PHI is valuated cheaply when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
PHI is valuated cheaply with a Price/Forward Earnings ratio of 7.71.
95.45% of the companies in the same industry are more expensive than PHI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of PHI to the average of the S&P500 Index (23.13), we can say PHI is valued rather cheaply.
Industry RankSector Rank
PE 8.17
Fwd PE 7.71
PHI Price Earnings VS Forward Price EarningsPHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

PHI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PHI is cheaper than 72.73% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as PHI.
Industry RankSector Rank
P/FCF 15.67
EV/EBITDA 5.54
PHI Per share dataPHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The excellent profitability rating of PHI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.58
EPS Next 2Y1.39%
EPS Next 3Y2.22%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.54%, PHI is a good candidate for dividend investing.
PHI's Dividend Yield is a higher than the industry average which is at 3.85.
PHI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 7.54%

5.2 History

The dividend of PHI has a limited annual growth rate of 5.62%.
PHI has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.62%
Div Incr Years0
Div Non Decr Years0
PHI Yearly Dividends per sharePHI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

PHI pays out 70.37% of its income as dividend. This is not a sustainable payout ratio.
The dividend of PHI is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP70.37%
EPS Next 2Y1.39%
EPS Next 3Y2.22%
PHI Yearly Income VS Free CF VS DividendPHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B 30B
PHI Dividend Payout.PHI Dividend Payout, showing the Payout Ratio.PHI Dividend Payout.PayoutRetained Earnings

PLDT INC-SPON ADR

NYSE:PHI (12/31/2025, 8:23:42 PM)

After market: 21.74 0 (0%)

21.74

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)02-25 2026-02-25
Inst Owners5.15%
Inst Owner Change-5.66%
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap4.70B
Revenue(TTM)219.17B
Net Income(TTM)29.25B
Analysts82.5
Price Target28.09 (29.21%)
Short Float %0.39%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield 7.54%
Yearly Dividend1.64
Dividend Growth(5Y)5.62%
DP70.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.38%
Min EPS beat(2)-9.26%
Max EPS beat(2)-3.5%
EPS beat(4)1
Avg EPS beat(4)-1.99%
Min EPS beat(4)-9.26%
Max EPS beat(4)5.39%
EPS beat(8)3
Avg EPS beat(8)1.52%
EPS beat(12)7
Avg EPS beat(12)10.07%
EPS beat(16)11
Avg EPS beat(16)11.63%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.54%
PT rev (3m)-4.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.83%
EPS NY rev (1m)-0.55%
EPS NY rev (3m)-0.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.55%
Revenue NY rev (3m)-0.55%
Valuation
Industry RankSector Rank
PE 8.17
Fwd PE 7.71
P/S 1.26
P/FCF 15.67
P/OCF 3.1
P/B 2.3
P/tB 4.95
EV/EBITDA 5.54
EPS(TTM)2.66
EY12.24%
EPS(NY)2.82
Fwd EY12.98%
FCF(TTM)1.39
FCFY6.38%
OCF(TTM)7.02
OCFY32.28%
SpS17.21
BVpS9.45
TBVpS4.4
PEG (NY)N/A
PEG (5Y)1.58
Graham Number23.78
Profitability
Industry RankSector Rank
ROA 4.65%
ROE 24.31%
ROCE 11.16%
ROIC 8.37%
ROICexc 8.56%
ROICexgc 9.96%
OM 23.74%
PM (TTM) 13.35%
GM 86.54%
FCFM 8.06%
ROA(3y)3.73%
ROA(5y)3.92%
ROE(3y)20.92%
ROE(5y)21.02%
ROIC(3y)5.82%
ROIC(5y)6.78%
ROICexc(3y)6.02%
ROICexc(5y)7.44%
ROICexgc(3y)7.16%
ROICexgc(5y)9.04%
ROCE(3y)7.76%
ROCE(5y)9.05%
ROICexgc growth 3Y-2.13%
ROICexgc growth 5Y-4.68%
ROICexc growth 3Y-0.98%
ROICexc growth 5Y-2.62%
OM growth 3Y1.9%
OM growth 5Y0.33%
PM growth 3Y2.8%
PM growth 5Y2.3%
GM growth 3Y-1.41%
GM growth 5Y-0.63%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 2.76
Debt/FCF 20.27
Debt/EBITDA 2.95
Cap/Depr 118.1%
Cap/Sales 32.72%
Interest Coverage 4.04
Cash Conversion 79.27%
Profit Quality 60.43%
Current Ratio 0.38
Quick Ratio 0.37
Altman-Z 0.84
F-Score6
WACC2.72%
ROIC/WACC3.08
Cap/Depr(3y)117.23%
Cap/Depr(5y)139.41%
Cap/Sales(3y)38.48%
Cap/Sales(5y)42.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.37%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%-10.71%
EPS Next Y-0.88%
EPS Next 2Y1.39%
EPS Next 3Y2.22%
EPS Next 5YN/A
Revenue 1Y (TTM)1.69%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%0.66%
Revenue Next Year1.37%
Revenue Next 2Y2%
Revenue Next 3Y2.17%
Revenue Next 5YN/A
EBIT growth 1Y19.15%
EBIT growth 3Y6.08%
EBIT growth 5Y5.44%
EBIT Next Year99.31%
EBIT Next 3Y28.02%
EBIT Next 5YN/A
FCF growth 1Y213.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.66%
OCF growth 3Y-3.86%
OCF growth 5Y3.33%

PLDT INC-SPON ADR / PHI FAQ

Can you provide the ChartMill fundamental rating for PLDT INC-SPON ADR?

ChartMill assigns a fundamental rating of 4 / 10 to PHI.


What is the valuation status for PHI stock?

ChartMill assigns a valuation rating of 6 / 10 to PLDT INC-SPON ADR (PHI). This can be considered as Fairly Valued.


How profitable is PLDT INC-SPON ADR (PHI) stock?

PLDT INC-SPON ADR (PHI) has a profitability rating of 8 / 10.


Can you provide the financial health for PHI stock?

The financial health rating of PLDT INC-SPON ADR (PHI) is 1 / 10.


How sustainable is the dividend of PLDT INC-SPON ADR (PHI) stock?

The dividend rating of PLDT INC-SPON ADR (PHI) is 5 / 10 and the dividend payout ratio is 70.37%.